Sorafenib for Treatment of Hepatocellular Carcinoma: A Systematic Review

被引：0
作者：
Bingru Xie
David H. Wang
Stuart Jon Spechler
机构：
[1] VA North Texas Healthcare System,Department of Medicine
[2] and the University of Texas Southwestern Medical Center at Dallas,Division of Gastroenterology (111B1)
[3] Dallas VA Medical Center,undefined
来源：
Digestive Diseases and Sciences | 2012年 / 57卷
关键词：
Sorafenib; Hepatocellular carcinoma; Cirrhosis; Transarterial chemoembolization; Systematic review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1122 / 1129
页数：7
相关论文
共 118 条
  • [1] Parkin DM(2005)Global cancer statistics, 2002 CA Cancer J Clin 55 74-108
  • [2] Bray F(2003)Hepatocellular carcinoma: a clinical update Med Gen Med 5 11-S94
  • [3] Ferlay J(2007)Epidemiology of hepatocellular carcinoma in USA Hepatol Res 37 S88-823
  • [4] Pons-Renedo F(2003)The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update Ann Intern Med 139 817-750
  • [5] Llovet JM(1999)Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 745-1128
  • [6] El-Serag HB(2006)Ubiquitous activation of Ras and Jak/stat pathways in human HCC Gastroenterology 130 1117-199
  • [7] El-Serag HB(2004)The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect Clin Ter 155 187-3884
  • [8] Davila JA(2006)New therapies for hepatocellular carcinoma Oncogene 25 3866-264
  • [9] Petersen NJ(1999)The molecular perspective: the Ras oncogene Oncologist 4 263-2610
  • [10] El-Serag HB(2003)Integrity of c-Raf-1/MEK signal transduction cascade is essential for hepatitis B virus gene expression Oncogene 22 2604-2610
12345678910